Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The nucleotide analogue prodrug remdesivir was among the first antiviral therapies to be tested in randomized controlled trials (RCTs) for COVID-19. We performed a meta-analysis to understand efficacy and safety. METHODS: We searched PubMed, EMBASE, Cochrane library, and ClinicalTrials.g...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Contemp Clin Trials
Prif Awduron: Al-Abdouh, Ahmad, Bizanti, Anas, Barbarawi, Mahmoud, Jabri, Ahmad, Kumar, Ashish, Fashanu, Oluwaseun E., Khan, Safi U., Zhao, Di, Antar, Annukka A.R., Michos, Erin D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier Inc. 2021
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789823/
https://ncbi.nlm.nih.gov/pubmed/33422642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2021.106272
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg